journal article·2015-08

Predictive evaluation of pharmaceutical properties of direct compression tablets containing theophylline anhydrate during storage at high humidity by near-infrared spectroscopy

Yuta Otsuka, Masahiro Yamamoto, Hideji Tanaka, Makoto Otsuka

Publisher page

Abstract

Abstract BACKGROUND: Theophylline anhydrate (TA) in tablet formulation is transformed into monohydrate (TH) at high humidity and the phase transformation affected dissolution behavior. OBJECTIVE: Near-infrared spectroscopic (NIR) method is applied to predict the change of pharmaceutical properties of TA tablets during storage at high humidity. METHODS: The tablet formulation containing TA, lactose, crystalline cellulose and magnesium stearate was compressed at 4.8 kN. Pharmaceutical properties of TA tables were measured by NIR, X-ray diffraction analysis, dissolution test and tablet hardness. RESULTS: TA tablet was almost 100% transformed into TH after 24 hours at RH 96%. The pharmaceutical properties of TA tablets, such as tablet hardness, 20 min dissolution amount (D20) and increase of tablet weight (TW), changed with the degree of hydration. Calibration models for TW, tablet hardness and D20 to predict the pharmaceutical properties at high-humidity conditions were developed on the basis of the NIR spectra by partial least squares regression analysis. The relationships between predicted and actual measured values for TW, tablet hardness and D20 had straight lines, respectively. CONCLUSIONS: From the results of NIR-chemometrics, it was confirmed that these predicted models had high accuracy to monitor the tablet properties during storage at high humidity.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Spectroscopy and Chemometric Analyses · Drug Solubulity and Delivery Systems · Pharmaceutical Quality and Counterfeiting

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Tokushima University

Konan University

Musashino University

References (18)

Show source-provided references
1. [1] U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Guidance for industry PAT – A framework for innovative pharmaceutical development manufacturing and quality assurance 2004 available at: http://www.fda.gov/downloads/Drugs/Guidances/ucm070305.pdf.
2. 10.1016/S0003-2670(99)00157-910.1016/S0003-2670(99)00157-9 ↗
3. 10.3109/0363904090353205310.3109/03639040903532053 ↗
4. 10.1016/j.powtec.2004.01.02510.1016/j.powtec.2004.01.025 ↗
5. 10.1002/jps.260052081510.1002/jps.2600520815 ↗
6. 10.1023/B:PHAM.0000012163.89163.f810.1023/B:PHAM.0000012163.89163.f8 ↗
7. [7] DebnathS. and SuryanarayananR., Influence of processing-induced phase transformations on the dissolution of theophylline tablets, AAPS PharmSciTech 5(1) (2004), 39–49.
8. 10.1208/pt06022610.1208/pt060226 ↗
9. 10.1002/jps.2053210.1002/jps.20532 ↗
10. 10.1111/j.2042-7158.1990.tb06616.x10.1111/j.2042-7158.1990.tb06616.x ↗
11. 10.1016/0378-5173(92)90144-Q10.1016/0378-5173(92)90144-Q ↗
12. 10.1016/j.colsurfb.2012.07.04910.1016/j.colsurfb.2012.07.049 ↗
13. [13] InfoMetrix Co. Software manual for Pirouette version 3.11 Woodinville WA.
14. [14] IwamotoM. KawanoS. and UozumiJ. Introduction of Near Infrared Spectroscopy Sachi Syobou Co. Tokyo Japan 1994.
15. 10.1255/jnirs.104010.1255/jnirs.1040 ↗
16. 10.2116/analsci.23.85710.2116/analsci.23.857 ↗
17. 10.1002/jps.2070410.1002/jps.20704 ↗
18. 10.1021/ja02086a00310.1021/ja02086a003 ↗